Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (221-230 of 743) with videos related to

Pageof 75
Sort By:
Pigment Cell & Melanoma Research|April 17, 2009
Id2 suppression of p15 counters TGF-beta-mediated growth inhibition of melanoma cellsNatalie C Schlegel, Ossia M Eichhoff, Silvio Hemmi, et al.
Current Oncology Reports|March 29, 2023
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?James P Pham, Anthony M Joshua, Ines P da Silva, et al.
Journal for Immunotherapy of Cancer|July 5, 2024
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroidsElias Burri, Joanna Mangana, Phil F Cheng, et al.
JAMA Oncology|August 10, 2023
Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma: A Randomized Clinical TrialReinhard Dummer, David E Gyorki, John R Hyngstrom, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 17, 2003
High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanomaGünther F L Hofbauer, Andrea Burkhart, Georges Schüler, et al.
Scientific Reports|June 11, 2015
TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic NeoplasmsSeungjae Lee, Raymond L Barnhill, Reinhard Dummer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 26, 2008
Short German guidelines: cutaneous lymphomasRudolf Stadler, Chalid Assaf, Claus-Detlev Klemke, et al.
Melanoma Research|November 6, 2010
The antibacterial substance, taurolidine in the second/third-line treatment of very advanced stage IV melanoma including brain metastases: results of a phase 2, open-label studyLaurence Imhof, Simone M Goldinger, Katrin Baumann, et al.
Dermatology (Basel, Switzerland)|April 8, 2016
Nevoid Basal Cell Carcinoma Syndrome: Report from the Zurich Nevoid Basal Cell Carcinoma Syndrome CohortSusanne Rehefeldt-Erne, Mirjam C Nägeli, Nina Winterton, et al.
British Journal of Haematology|August 30, 2002
The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomasCornelia Schwab, Jörg Willers, Eva Niederer, et al.
Pageof 75

Showing results (221-230 of 743) with videos related to

Sort By:
Pageof 75
Pigment Cell & Melanoma Research|April 17, 2009
Id2 suppression of p15 counters TGF-beta-mediated growth inhibition of melanoma cellsNatalie C Schlegel, Ossia M Eichhoff, Silvio Hemmi, et al.
Current Oncology Reports|March 29, 2023
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?James P Pham, Anthony M Joshua, Ines P da Silva, et al.
Journal for Immunotherapy of Cancer|July 5, 2024
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroidsElias Burri, Joanna Mangana, Phil F Cheng, et al.
JAMA Oncology|August 10, 2023
Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma: A Randomized Clinical TrialReinhard Dummer, David E Gyorki, John R Hyngstrom, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 17, 2003
High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanomaGünther F L Hofbauer, Andrea Burkhart, Georges Schüler, et al.
Scientific Reports|June 11, 2015
TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic NeoplasmsSeungjae Lee, Raymond L Barnhill, Reinhard Dummer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 26, 2008
Short German guidelines: cutaneous lymphomasRudolf Stadler, Chalid Assaf, Claus-Detlev Klemke, et al.
Melanoma Research|November 6, 2010
The antibacterial substance, taurolidine in the second/third-line treatment of very advanced stage IV melanoma including brain metastases: results of a phase 2, open-label studyLaurence Imhof, Simone M Goldinger, Katrin Baumann, et al.
Dermatology (Basel, Switzerland)|April 8, 2016
Nevoid Basal Cell Carcinoma Syndrome: Report from the Zurich Nevoid Basal Cell Carcinoma Syndrome CohortSusanne Rehefeldt-Erne, Mirjam C Nägeli, Nina Winterton, et al.
British Journal of Haematology|August 30, 2002
The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomasCornelia Schwab, Jörg Willers, Eva Niederer, et al.
Pageof 75